Zacks Research Has Negative Outlook for Clorox Q2 Earnings

The Clorox Company (NYSE:CLX) – Analysts at Zacks Research cut their Q2 2027 earnings estimates for shares of Clorox in a research report issued on Monday, August 17th. Zacks Research analyst Team now expects that the company will post earnings of $1.36 per share for the quarter, down from their prior forecast of $1.44. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $5.82 per share. Zacks Research also issued estimates for Clorox’s Q3 2027 earnings at $1.62 EPS, Q4 2027 earnings at $1.82 EPS, FY2027 earnings at $5.82 EPS, Q1 2028 earnings at $1.10 EPS, Q2 2028 earnings at $1.55 EPS, Q3 2028 earnings at $1.77 EPS, Q4 2028 earnings at $1.81 EPS, FY2028 earnings at $6.23 EPS and FY2029 earnings at $6.89 EPS.

CLX has been the topic of a number of other reports. Citigroup lifted their price objective on Clorox from $97.00 to $100.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. Wells Fargo & Company raised their price target on shares of Clorox from $95.00 to $102.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 4th. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. Wall Street Zen downgraded shares of Clorox from a “hold” rating to a “sell” rating in a research note on Saturday. Finally, Evercore set a $99.00 target price on shares of Clorox in a report on Tuesday, August 4th. Twelve investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average target price of $102.40.

Clorox Stock Up 0.3%

Shares of CLX opened at $106.01 on Tuesday. The company has a market capitalization of $12.82 billion, a PE ratio of 21.99, a PEG ratio of 3.15 and a beta of 0.54. The stock’s 50-day moving average price is $98.30 and its two-hundred day moving average price is $103.19. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. Clorox has a 12 month low of $84.70 and a 12 month high of $128.90.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The firm had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter last year, the firm earned $2.87 earnings per share. The company’s revenue for the quarter was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Clorox by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after purchasing an additional 514 shares in the last quarter. Woodline Partners LP increased its position in Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares in the last quarter. Baird Financial Group Inc. raised its stake in Clorox by 1.7% during the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after buying an additional 424 shares during the period. Jump Financial LLC boosted its holdings in Clorox by 173.5% in the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after acquiring an additional 7,924 shares in the last quarter. Finally, Bank of Nova Scotia grew its stake in Clorox by 26.2% in the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after acquiring an additional 3,352 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 4.7%. The ex-dividend date is Wednesday, August 12th. This is a boost from Clorox’s previous quarterly dividend of $1.24. Clorox’s dividend payout ratio is presently 103.73%.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Zacks raised its Q3 2027 EPS forecast to $1.62 from $1.57 and its Q4 2027 forecast to $1.82 from $1.71, suggesting stronger projected earnings in the second half of fiscal 2027.
• Positive Sentiment: The firm also increased its Q3 2028 estimate to $1.77 from $1.76 and its Q4 2028 estimate to $1.81 from $1.73. Zacks projects FY2029 EPS of $6.89, above the current-year consensus estimate of $5.82, indicating expected longer-term earnings growth.
• Neutral Sentiment: The revisions leave Zacks’ FY2027 EPS estimate at $5.82 and establish forecasts of $6.23 for FY2028 and $6.89 for FY2029. These figures imply growth over time, but the analyst did not change its overall “Strong Sell” view.
• Negative Sentiment: Zacks cut its Q2 2027 EPS estimate to $1.36 from $1.44, lowering expectations for the near-term earnings outlook.
• Negative Sentiment: The firm reduced its Q1 2028 forecast to $1.10 from $1.28 and Q2 2028 forecast to $1.55 from $1.59, pointing to weaker projected results early in fiscal 2028.
• Negative Sentiment: Full-year forecasts were also trimmed: FY2027 EPS fell to $5.82 from $6.00 and FY2028 EPS declined to $6.23 from $6.36. These cuts outweigh the modest quarterly upgrades and reinforce concerns about Clorox’s earnings momentum.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.